Latest Prescription Drugs news
ASCO: Ramucirumab Plus Pembrolizumab Promising in NSCLC
posted June 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASCO: Desmoplastic Melanoma Responds to Neoadjuvant Pembrolizumab
posted June 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
More Clinical Benefits of Molnupiravir ID’d in COVID-19
posted June 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
ADA: Once-Weekly Dulaglutide Ups Glycemic Control in Youth With T2D
posted June 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
EHR-Enabled QI Intervention Improves Chlamydia, Gonorrhea Screening in Teens 
Weight-Loss Surgery Produces Lasting Diabetes Remission 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy Related Articles
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing Monthly Specialist Briefings
Stay Connected
